Crinecerfont decreases glucocorticoid use in adults with congenital adrenal hyperplasia
1. In this randomized controlled trial, twice daily crinecerfont use was associated with reduced daily glucocorticoid use in adults with ...
Tag: endocrinology
Crinecerfont facilitates glucocorticoid dose reduction in pediatric congenital adrenal hyperplasia
1. In this randomized controlled trial of pediatric patients with congenital adrenal hyperplasia (CAH), it was found that treatment with ...
Biguanides and dipeptidyl peptidase-4 inhibitors use have similar outcomes for diabetic patients
1. Biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors show no differences in major cardiac or cerebrovascular events, diabetic complications, or death ...
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
2 Minute Medicine Rewind August 12, 2024
Comparing the effects of biguanides and dipeptidyl peptidase-4 inhibitors on cardiocerebrovascular outcomes, nephropathy, retinopathy, neuropathy, and treatment costs in diabetic ...
2 Minute Medicine Rewind July 15, 2024
Fairness in Predicting Cancer Mortality Across Racial Subgroups 1. A machine learning model trained on retrospective data of patients with ...
#VisualAbstract: Targeting a Systolic Blood Pressure of <120 mmHg Reduces Vascular Events in High-risk Cardiovascular Patients
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Periodontitis in patients with diabetes and its association with diabetes-related complication
1. Periodontitis has a strong association with Type 2 Diabetes and is exacerbated by poor glycemic control. 2. Type 1 ...
2 Minute Medicine Rewind July 7, 2024
Web-Based Cognitive Behavioral Treatment for Bulimia Nervosa A Randomized Clinical Trial 1. Patients with bulimia nervosa randomized to receive web-based ...
Metformin may reduce all-cause mortality in cancer survivors
1. Among US cancer survivors, metformin was associated with a lower risk of cardiometabolic diseases, all-cause mortality, and cardiometabolic mortality. ...